These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19861348)

  • 1. The past, present and future of angiotensin II type 2 receptor stimulation.
    Steckelings UM; Rompe F; Kaschina E; Namsolleck P; Grzesiak A; Funke-Kaiser H; Bader M; Unger T
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):67-73. PubMed ID: 19861348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of selective non-peptide angiotensin II type 2 receptor agonists.
    Alterman M
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):57-66. PubMed ID: 19880657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.
    Wan Y; Wallinder C; Plouffe B; Beaudry H; Mahalingam AK; Wu X; Johansson B; Holm M; Botoros M; Karlén A; Pettersson A; Nyberg F; Fändriks L; Gallo-Payet N; Hallberg A; Alterman M
    J Med Chem; 2004 Nov; 47(24):5995-6008. PubMed ID: 15537354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic expression of the angiotensin II type 2 receptor and duodenal mucosal alkaline secretion in the Sprague-Dawley rat.
    Ewert S; Sjoberg T; Johansson B; Duvetorp A; Holm M; Fandriks L
    Exp Physiol; 2006 Jan; 91(1):191-9. PubMed ID: 16263801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current.
    Caballero R; Gómez R; Moreno I; Nuñez L; González T; Arias C; Guizy M; Valenzuela C; Tamargo J; Delpón E
    Cardiovasc Res; 2004 Apr; 62(1):86-95. PubMed ID: 15023555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative inotropic effect of selective AT2 receptor stimulation and its modulation by the endocardial endothelium.
    Castro-Chaves P; Soares S; Fontes-Carvalho R; Leite-Moreira AF
    Eur J Pharmacol; 2008 Jan; 578(2-3):261-9. PubMed ID: 17961546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential.
    Unger T; Dahlöf B
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):75-7. PubMed ID: 19861350
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage.
    Gelosa P; Pignieri A; Fändriks L; de Gasparo M; Hallberg A; Banfi C; Castiglioni L; Turolo L; Guerrini U; Tremoli E; Sironi L
    J Hypertens; 2009 Dec; 27(12):2444-51. PubMed ID: 19680135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?
    Kaschina E; Grzesiak A; Li J; Foryst-Ludwig A; Timm M; Rompe F; Sommerfeld M; Kemnitz UR; Curato C; Namsolleck P; Tschöpe C; Hallberg A; Alterman M; Hucko T; Paetsch I; Dietrich T; Schnackenburg B; Graf K; Dahlöf B; Kintscher U; Unger T; Steckelings UM
    Circulation; 2008 Dec; 118(24):2523-32. PubMed ID: 19029468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiotensin II type 2 receptor in cardiovascular disease.
    Lemarié CA; Schiffrin EL
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):19-31. PubMed ID: 19861349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
    Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
    Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CNS renin-angiotensin system.
    von Bohlen und Halbach O; Albrecht D
    Cell Tissue Res; 2006 Nov; 326(2):599-616. PubMed ID: 16555051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides as targets for antihypertensive drug development.
    Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin II type 2 receptor in renal disease.
    Wenzel UO; Krebs C; Benndorf R
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):37-41. PubMed ID: 19861345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
    Lakó-Futó Z; Szokodi I; Sármán B; Földes G; Tokola H; Ilves M; Leskinen H; Vuolteenaho O; Skoumal R; deChâtel R; Ruskoaho H; Tóth M
    Circulation; 2003 Nov; 108(19):2414-22. PubMed ID: 14568903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo.
    Wan Y; Wallinder C; Johansson B; Holm M; Mahalingam AK; Wu X; Botros M; Karlén A; Pettersson A; Nyberg F; Fändriks L; Hallberg A; Alterman M
    J Med Chem; 2004 Mar; 47(6):1536-46. PubMed ID: 14998339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympatho-inhibitory properties of various AT1 receptor antagonists.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II receptors-antagonists, molecular biology, and signal transduction.
    Jagadeesh G
    Indian J Exp Biol; 1998 Dec; 36(12):1171-94. PubMed ID: 10093499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.